<i>Bifidobacterium stercoris</i> KC84 attenuates IBS-D-like symptoms via modulation of serotonin-related pathways and dendritic cell-mediated IFN-β induction.

Curr Res Microb Sci · 2026 · PMC13200085 · PMID 42199361

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a decreasing trendp = 0.06so close (0.05 < p ≤ 0.1)

Consistently, targeted LC-MS analysis revealed a decreasing trend in luminal serotonin levels in the KC84-treated group ( p = 0.06; Fig. 3 C).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

&lt;i&gt;Bifidobacterium stercoris&lt;/i&gt; KC84 attenuates IBS-D-like symptoms via modulation of serotonin-related pathways and dendritic cell-mediated IFN-β induction.

The sentences

<i>Bifidobacterium stercoris</i> KC84 attenuates IBS-D-like symptoms via modulation of serotonin-related pathways and dendritic cell-mediated IFN-β induction.